glp-1 and inflammation Anti-Inflammatory Effects of Receptor Activation in the Brain in Neurodegenerative Diseases Beneficial Effects of Glucagon-Like Peptide-1
Description
GLP-1 receptor agonist as treatment for cancer as well as diabetes: beyond blood glucose control

Hermansen K, Kipnes M, Luo E, et al

Compared to GLP-1 RAs, no significant difference was observed in the post-interventional hsCRP levels with SGLT2is (WMD: 1.69

These studies indicate an increased risk for serious, potentially life-altering conditions such as gastroparesis, blood clots, and vision loss associated with the use of the drug

Look for clear dosing disclosure, third-party testing transparency, and avoidance of drug-like promises

Load up on the veggies for volume and nutrients without excessive fat that can trigger nausea
